HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden
María Cristina Ferrara, Giovanni Guaraldi(University of Modena and Reggio Emilia), Stefano Zona(University of Modena and Reggio Emilia), Chiara Stentarelli(University of Modena and Reggio Emilia), Andrea Malagoli, Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena), Pamela Raggi, Federica Carli(Istituto di Fisiologia Clinica), Sara Garlassi, Antonella Santoro(University of Modena and Reggio Emilia), Cristina Mussini(University of Modena and Reggio Emilia), Fabrizio Starace(Ospedale D. Cotugno)
IRIS UNIMORE (University of Modena and Reggio Emilia)
January 1, 2015
Cited by 0
Related Papers
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
|The Lancet Regional Health - Europe|2022|348